Projects per year
Personal profile
Area of Expertise
Dr. Prokai is the first Chair in Biochemistry endowed by the Houston-based Welch Foundation, one of the United States’ oldest and largest private funding sources for basic research, at UNT Health Science Center. He is affiliated with UNTHSC’s Department of Pharmacology and Neuroscience, and with the Institute of Healthy Aging. Dr. Prokai also is Adjunct Professor at the Department of Chemistry and Biochemistry, University of Texas at Arlington, as well as Adjunct Professor and Associate Member of the Graduate Faculty at the Department of Chemistry and Biochemistry of Texas Christian University.
His interests focus on chemistry-driven multidisciplinary research and include the discovery, chemical biology, bioorganic, and medicinal chemistry of central nervous system agents, as well as neuropeptides, proteomics, and mass spectrometry.
Dr. Prokai has maintained an actively funded research program from grant support by the National Institutes of Health (NIH) as well as through collaborations with pharmaceutical and chemical companies. Dr. Prokai was the recipient of the 2017 Wilfred T. Doherty Award of the Dallas/Fort Worth Section of the American Chemical Society (ACS) and the 2017 Southwest ACS Regional Award.
His interests focus on chemistry-driven multidisciplinary research and include the discovery, chemical biology, bioorganic, and medicinal chemistry of central nervous system agents, as well as neuropeptides, proteomics, and mass spectrometry.
Dr. Prokai has maintained an actively funded research program from grant support by the National Institutes of Health (NIH) as well as through collaborations with pharmaceutical and chemical companies. Dr. Prokai was the recipient of the 2017 Wilfred T. Doherty Award of the Dallas/Fort Worth Section of the American Chemical Society (ACS) and the 2017 Southwest ACS Regional Award.
Education/Academic qualification
MS in Chemistry, University of Veszprem
BS in Chemical Engineering, University of Veszprem
PhD in Radiochemistry, University of Veszprem
Fingerprint
Dive into the research topics where Laszlo Prokai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
Prokai, L., MERCHENTHALER, I. J., PUCHE, A., Prokai, L., Merchenthaler, I. & PUCHE, A.
15/01/21 → 31/12/22
Project: Research
-
Impact of brain estrogens on cognition and brain aging in a non-human primate
Prokai, L., LACREUSE, A., MERCHENTHALER, I. J., Prokai, L., LACREUSE, A. & Merchenthaler, I.
1/01/21 → 31/12/22
Project: Research
-
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
-
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
-
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
Prokai, L., MERCHENTHALER, I. J. & PUCHE, A.
15/01/21 → 31/12/21
Project: Research
-
Global Comparative Label-Free Yeast Proteome Analysis by LC-MS/MS After High-pH Reversed-Phase Peptide Fractionation Using Solid-Phase Extraction Cartridges
Zaman, K., Pandey, P., Shulaev, V. & Prokai, L., 2022, Methods in Molecular Biology. Humana Press Inc., p. 71-84 14 p. (Methods in Molecular Biology; vol. 2396).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
[β-glu2 ]trh is a functional antagonist of thyrotropin-releasing hormone (Trh) in the rodent brain
Prokai-Tatrai, K., Nguyen, V. & Prokai, L., 2 Jun 2021, In: International journal of molecular sciences. 22, 12, 6230.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Comparative proteomics analysis reveals unique early signaling response of saccharomyces cerevisiae to oxidants with different mechanism of action
Pandey, P., Zaman, K., Prokai, L. & Shulaev, V., 1 Jan 2021, In: International journal of molecular sciences. 22, 1, p. 1-17 17 p., 167.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Oligo(amylene) from the reaction of fusel oil with zinc dihalide
Davis, M. C., Prokai, L. & Woodroffe, J. D., 7 Jan 2021, In: RSC Advances. 11, 4, p. 1960-1968 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Proteomics-based retinal target engagement analysis and retina-targeted delivery of 17β-estradiol by the dhed prodrug for ocular neurotherapy in males
Prokai-Tatrai, K., Zaman, K., Nguyen, V., De La Cruz, D. L. & Prokai, L., Sep 2021, In: Pharmaceutics. 13, 9, 1392.Research output: Contribution to journal › Article › peer-review
Open Access